Indian government has made crucial changes in order to welcome the multinational pharma companies for conducting clinical trials to attract foreign investments and achieve technological gains. In this regard, we also need to remember that the trials should be conducted in public health interest without violating the humanitarian ethics and other social norms. This article reviews advantages and disadvantages of conducting clinical trials in India.
Last year Indian government made crucial changes in the regulation of clinical trials in India to conduct the clinical trials with maximum transparency, predictability, and accountability. These changes would enable the investors to make their applications in a more systematic manner, saving time and resources. Although the government welcomes the multinational pharma companies for conducting a clinical trial to attract foreign investments…
